Header

For Healthcare Professionals

About Us Opens in new tab

Contact Opens in new tab

Global Website Opens in new tab

Top Navigation - Boehringer Ingelheim Logo

Oncology Pipeline
Oncology Pipeline

Our generational commitment to driving scientific innovation is reflected by our robust pipeline of cancer cell-directed and immuno-oncology investigational therapies, as well as the smart combination of these approaches.
Section Overview

Oncology Pipeline

HER2 TKI-zongertinib

DLL3/CD3 T-cell engager obrixtamig

B7-H6/CD3 T-cell engager

PD-1 inhibitor-ezabenlimab

CD137 FAP bispecific agonist antibody

SIRPα antagonist

VSV-GP oncolytic viruses

KISIMA cancer vaccine (ATP150/ATP152/ATP162, VSV-GP154 + ezabenlimab)

2nd generation STING agonist

KRAS multi-inhibitor
Tumor Types in Focus
Tumor Types in Focus

Get an overview of different cancer types and how recent advances may affect clinical decision making and treatment of these cancers.
Section Overview

Tumor Types in Focus

Non-small cell lung cancer

Small cell lung cancer

Gastrointestinal cancers

Head and neck squamous cell carcinoma

Glioblastoma
Collaborations
Our Collaborators

We are taking a diligent and broad approach, creating a collaborative research network to tap into a diversity of minds, which is vital in addressing some of the most challenging, but potentially most impactful, areas of cancer research.
Section Overview

Collaborations

Collaborations
About Us Opens in new tab
Contact Opens in new tab
Global Website Opens in new tab

Top Navigation - Boehringer Ingelheim Logo

SITEMAP

HOME

Oncology Research Pipeline

HER2 TKI-zongertinib

DLL3/CD3 T-cell engager obrixtamig

B7-H6/CD3 T-cell engager

PD-1 inhibitor-ezabenlimab

CD137 FAP bispecific agonist antibody

SIRPα antagonist

VSV-GP oncolytic viruses

KISIMA cancer vaccine (ATP150/ATP152/ATP162, VSV-GP154)

2nd generation STING agonist

KRAS multi-inhibitor

TUMOR TYPES IN FOCUS

Non-small cell lung cancer

Small cell lung cancer

Gastrointestinal cancers

Head and neck squamous cell carcinoma

Glioblastoma

COLLABORATIONS

Home
Sitemap

Footer Navigation - Boehringer Ingelheim Logo

Accessibility 
StatementOpens in new tab
Terms of UseOpens in new tab
ImprintOpens in new tab
US Privacy 
StatementOpens in new tab
Consumer Health Data 
Privacy StatementOpens in new tab
Cookie 
StatementOpens in new tab
Do Not Sell or Share My 
Personal DataOpens in new tab
Limit the Use of My Sensitive DataOpens in new tab
Contact Us Opens in new tab
Sitemap

Pipeline compounds shown in this website are under pre-clinical and/or clinical investigation and have not been approved by regulatory authorities for commercial use in patients. Efficacy and safety have not been established and there is no guarantee that they will become commercially available for the uses under investigation.